Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs to Determine the Efficacy in Treatment of Advanced Cancers With a Known Molecular Profile

NCT05159245 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT05159245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05159245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs to Determine the Efficacy in Treatment of Advanced Cancers With a Known Molecular Profile
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
December 10, 2021
Completion date
November 25, 2026
Enrollment
250 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, haematological malignancy, solid tumor